Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical reviews in allergy and immunology

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1385/CRIAI:27:1:059PMID 15347851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone.

  2003cited by this paper
• Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.

  2002cited by this paper
• A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

  2002cited by this paper
• Mediator involvement in antigen‐induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats

  2001cited by this paper
• Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma

  2001cited by this paper
• A mechanism of antigen-induced mucus production in nasal epithelium of sensitized rats. A comparison with lipopolysaccharide-induced mucus production.

  2000cited by this paper
• Long-term effects of budesonide or nedocromil in children with asthma.

  2000cited by this paper
• Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma.

  1999cited by this paper
• Vascularity in asthmatic airways: relation to inhaled steroid dose.

  1999cited by this paper
• Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

  1999cited by this paper
• Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

  1998cited by this paper
• Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

  1998cited by this paper
• Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin‐sensitized guinea‐pigs in vitro

  1998cited by this paper
• Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma

  1998cited by this paper
• Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'.

  1997cited by this paper
• Inflammation of small airways in asthma.

  1997cited by this paper
• Bronchial blood vessel dimensions in asthma.

  1997cited by this paper
• Increased vascularity of the bronchial mucosa in mild asthma.

  1997cited by this paper
• Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.

  1997cited by this paper
• Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups.

  1996cited by this paper
• A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings.

  1996cited by this paper
• Human airway narrowing measured using high resolution computed tomography.

  1996cited by this paper
• Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.

  1995cited by this paper
• Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

  1994cited by this paper
• Decline of lung function in adults with bronchial asthma.

  1994cited by this paper
• Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.

  1994cited by this paper
• Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

  1994cited by this paper
• Small airways dimensions in asthma and in chronic obstructive pulmonary disease.

  1993cited by this paper
• Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat.

  1993cited by this paper
• Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma.

  1992cited by this paper
• Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study.

  1992cited by this paper
• Inhaled beclomethasone improves the course of asthma and COPD.

  1992cited by this paper
• Effect of cessation of exposure to toluene diisocyanate (TDI) on bronchial mucosa of subjects with TDI-induced asthma.

  1992cited by this paper
• Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.

  1992cited by this paper
• Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

  1991cited by this paper
• Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid.

  1991cited by this paper
• Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids.

  1988cited by this paper
• Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

  1987cited by this paper
• THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSA

  1960cited by this paper

• NLRP3 inflammasome expression in pediatric asthma: sputum-based insights, inflammatory mechanisms, and targeted therapeutic strategies

  2025cites this paper
• Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma

  2024cites this paper
• Neutrophil-Derived Exosomes: A New Mechanism Contributing to Airway Smooth Muscle Remodeling.

  2016cites this paper
• Allergic Asthma: A Summary from Genetic Basis, Mouse Studies, to Diagnosis and Treatment.

  2016cites this paper
• BRONCHIAL ASTHMA; DURATION OF ASTHMA IS NOT CORRELATED WITH TOTAL ANTI OXIDANT CAPACITY AND LUNG FUNCTION PARAMETERS

  2015cites this paper
• The Properties of Circulating Fibrocytes in Severe Asthma

  2014cites this paper
• Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis.

  2014cites this paper
• Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease.

  2013cites this paper
• What effect does asthma treatment have on airway remodeling? Current perspectives.

  2011cites this paper
• Marine macro- and microalgae as potential agents for the prevention of asthma: hyperresponsiveness and inflammatory subjects.

  2011cites this paper
• Remodeling of the lower and upper airways Summary

  2009cites this paper
• Remodeling of the lower and upper airways.

  2009cites this paper
• Chapter 24 – Leukotrienes and Lipoxins

  2009cites this paper
• Remodelamento das vias aéreas inferiores e superiores

  2009cites this paper
• Chapter 33 – Pathophysiology of Asthma

  2009cites this paper
• Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling

  2007cites this paper
• VEGF, angiopoietin-1 and -2 in bronchial asthma: new molecular targets in airway angiogenesis and microvascular remodeling.

  2007cites this paper
• Therapeutic approach to vascular remodelling in asthma.

  2007cites this paper
• Airway remodeling and lack of bronchodilator response in steroid-resistant asthma.

  2007cites this paper
• Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus‐induced epithelial production of remodelling‐associated growth factors

  2006cites this paper
• Airway remodelling in asthma: current understanding and implications for future therapies.

  2006cites this paper